Mycenax Biotech (4726) — Capital Reinvestment Ratio
Mycenax Biotech (4726) has a Capital Reinvestment Ratio of 5.90x as of March 2025, meaning it reinvests 6% of its operating cash flow (NT$14.29 Million) in capital expenditures (NT$84.30 Million). See Mycenax Biotech net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Mycenax Biotech Capital Reinvestment Ratio (2020–2020)
This chart tracks Mycenax Biotech's Capital Reinvestment Ratio across 1 annual periods. Check Mycenax Biotech investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Mycenax Biotech (2020–2020)
Year-by-year Capital Reinvestment Ratio for Mycenax Biotech from 2020 to 2020. For live market cap and broader valuation context, see Mycenax Biotech market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 1.49x | NT$174.17 Million | NT$260.22 Million | — |